Prothrombin Complex Concentrate (Human) comment watch save
BreastfeedingPediatric

  • TRADE NAME: Kcentra (CSL Behring)
  • INDICATIONS: Urgent reversal of acquired coagulation factor deficiency induced by vitamin K antagonist therapy in adult patients with acute major bleeding
  • SYNONYM: PCC
  • CLASS: Coagulant
  • HALF-LIFE: 4–60 hours
  • CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
    None known

ARTERIAL AND VENOUS THROMBOEMBOLIC COMPLICATIONS

See full prescribing information for complete boxed warning.

Please login to view the rest of this drug profile.

Page last updated 07/31/2023

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric